EW in the 13F filings
Edwards Lifesciences Corp · CUSIP 28176E108
- Quarter end
- 31 Dec 2024
- the date the book describes
- Filed
- 14 Feb 2025
- latest of these filings; the earliest 31 Jan 2025
- Managers listing it
- 22
- at least, of 95 tracked, among listed positions
- Comparable managers
- 94
- filed both Q3 2024 and Q4 2024; 14 listed it in both
- Shares listed
- 68,092,797
- combined, among listed positions
- Reported value
- $5.0bn
- combined, at the quarter end
Among the 94 comparable managers: 12 buyers (opened or added shares) and 11 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing EW in Q4 2024
22 of 22 holders
Largest increases and reductions, by shares
Increases
- Marshall Wace LLPexisting position · 5,813,419 shares now+2,079,642
- Wellington Management Group LLPexisting position · 33,210,879 shares now+1,678,154
- Balyasny Asset Management LLCexisting position · 1,395,178 shares now+675,651
- Point72 Asset Management LPnew position · 588,206 shares now+588,206
- Baillie Gifford & Coexisting position · 706,796 shares now+498,100
Reductions
- AllianceBernstein LPexisting position · 2,038,677 shares now-4,944,582
- Voloridge Investment Management LLCexisting position · 383,606 shares now-1,272,304
- Renaissance Technologies LLCexisting position · 652,493 shares now-569,207
- Holocene Advisors LPexisting position · 2,410,085 shares now-397,382
- T. Rowe Price Associates Incexisting position · 3,297,722 shares now-244,061
New positions and exits
New (3)
Exited (2)
- Quantbot Technologies LPwas $14m
- Maverick Capital Ltdwas $2.0m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 6 | $2.5bn | n.a. | n.a. |
| Q3 2013 | 14 | $2.3bn | n.a. | n.a. |
| Q4 2013 | 8 | $2.4bn | n.a. | n.a. |
| Q1 2014 | 10 | $2.9bn | n.a. | n.a. |
| Q2 2014 | 7 | $3.0bn | n.a. | n.a. |
| Q3 2014 | 13 | $2.9bn | n.a. | n.a. |
| Q4 2014 | 18 | $3.4bn | n.a. | n.a. |
| Q1 2015 | 18 | $3.1bn | n.a. | n.a. |
| Q2 2015 | 15 | $2.3bn | n.a. | n.a. |
| Q3 2015 | 16 | $2.8bn | n.a. | n.a. |
| Q4 2015 | 19 | $2.7bn | n.a. | n.a. |
| Q1 2016 | 20 | $2.7bn | n.a. | n.a. |
| Q2 2016 | 26 | $3.1bn | n.a. | n.a. |
| Q3 2016 | 21 | $3.8bn | n.a. | n.a. |
| Q4 2016 | 18 | $2.8bn | n.a. | n.a. |
| Q1 2017 | 23 | $2.0bn | n.a. | n.a. |
| Q2 2017 | 21 | $2.8bn | n.a. | n.a. |
| Q3 2017 | 24 | $2.7bn | n.a. | n.a. |
| Q4 2017 | 25 | $2.8bn | n.a. | n.a. |
| Q1 2018 | 23 | $3.7bn | n.a. | n.a. |
| Q2 2018 | 23 | $4.1bn | n.a. | n.a. |
| Q3 2018 | 17 | $5.2bn | n.a. | n.a. |
| Q4 2018 | 21 | $5.0bn | n.a. | n.a. |
| Q1 2019 | 23 | $6.1bn | n.a. | n.a. |
| Q2 2019 | 23 | $5.7bn | n.a. | n.a. |
| Q3 2019 | 24 | $6.7bn | n.a. | n.a. |
| Q4 2019 | 28 | $7.2bn | n.a. | n.a. |
| Q1 2020 | 29 | $5.8bn | n.a. | n.a. |
| Q2 2020 | 30 | $5.9bn | n.a. | n.a. |
| Q3 2020 | 21 | $6.1bn | n.a. | n.a. |
| Q4 2020 | 14 | $6.3bn | n.a. | n.a. |
| Q1 2021 | 22 | $6.0bn | n.a. | n.a. |
| Q2 2021 | 25 | $7.7bn | n.a. | n.a. |
| Q3 2021 | 22 | $8.5bn | n.a. | n.a. |
| Q4 2021 | 20 | $9.2bn | n.a. | n.a. |
| Q1 2022 | 22 | $7.9bn | n.a. | n.a. |
| Q2 2022 | 22 | $6.6bn | n.a. | n.a. |
| Q3 2022 | 29 | $6.2bn | n.a. | n.a. |
| Q4 2022 | 28 | $5.8bn | n.a. | n.a. |
| Q1 2023 | 26 | $5.8bn | n.a. | n.a. |
| Q2 2023 | 25 | $5.9bn | n.a. | n.a. |
| Q3 2023 | 25 | $4.6bn | n.a. | n.a. |
| Q4 2023 | 22 | $5.1bn | 10 | 12 |
| Q1 2024 | 23 | $7.0bn | 14 | 13 |
| Q2 2024 | 20 | $6.8bn | 12 | 11 |
| Q3 2024 | 19 | $3.8bn | 11 | 9 |
| Q4 2024 | 22 | $5.0bn | 12 | 11 |
| Q1 2025 | 23 | $5.0bn | 14 | 11 |
| Q2 2025 | 23 | $5.2bn | 17 | 7 |
| Q3 2025 | 22 | $5.0bn | 9 | 15 |
| Q4 2025 | 23 | $5.9bn | 22 | 14 |
| Q1 2026 | 25 | $6.0bn | 15 | 21 |
| Q2 2026 | 25 | $6.9bn | 18 | 17 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
EW and LLY →EW and JNJ →EW and VRTX →Choose a stock to compare with EW →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own EW, latest filings →Back to the 13F Explorer →